{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Control&page=120", "query": { "intervention": "Standard Control", "page": 120 }, "page_size": 10 }, "pagination": { "page": 120, "page_size": 10, "total_count": 7489, "total_pages": 749, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Control&page=121&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+Control&page=119&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-08T07:26:02.298Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00496678", "title": "Trial of Patient Navigation-Activation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Breast Cancer", "Colorectal Cancer" ], "interventions": [ { "name": "Navigation", "type": "BEHAVIORAL" }, { "name": "Standard of Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2007-04", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2013-08-09", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00496678" }, { "nct_id": "NCT04505774", "title": "Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "theraputic heparin", "type": "DRUG" }, { "name": "prophylactic heparin", "type": "DRUG" }, { "name": "P2Y12", "type": "DRUG" }, { "name": "Crizanlizumab Injection", "type": "DRUG" }, { "name": "SGLT2 inhibitor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Matthew Neal MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3591, "start_date": "2020-09-04", "completion_date": "2024-01-26", "has_results": true, "last_update_posted_date": "2024-12-30", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 65 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fontana", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04505774" }, { "nct_id": "NCT01939210", "title": "Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety", "Depression", "Digestive System Neoplasm", "Lung Neoplasm", "Pain", "Post-Traumatic Stress Disorder", "Psychological Impact of Cancer" ], "interventions": [ { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Meditation Therapy", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2010-02", "completion_date": "2015-12-02", "has_results": false, "last_update_posted_date": "2018-05-18", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01939210" }, { "nct_id": "NCT01508910", "title": "Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Myocardial Ischemia", "Refractory Angina Pectoris", "Advanced Coronary Heart Disease" ], "interventions": [ { "name": "Auto-CD34+ cells", "type": "BIOLOGICAL" }, { "name": "Placebo: Diluent used to suspend Auto-CD34+ cells", "type": "BIOLOGICAL" }, { "name": "Standard of care", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Lisata Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 291, "start_date": "2012-04", "completion_date": "2015-11", "has_results": true, "last_update_posted_date": "2018-12-19", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01508910" }, { "nct_id": "NCT06138808", "title": "5-SENSE Score Validation Study", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Epilepsy Intractable" ], "interventions": [ { "name": "Stereoelectroencephalography (SEEG)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 400, "start_date": "2024-01-09", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 4, "location_summary": "Gainesville, Florida • Chicago, Illinois • Durham, North Carolina + 1 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06138808" }, { "nct_id": "NCT01223274", "title": "Delivery Room CPAP in Extremely Low Birth Weight Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Infant, Newborn", "Infant, Low Birth Weight", "Infant, Small for Gestational Age", "Infant, Premature", "Bronchopulmonary Dysplasia", "Continuous Positive Airway Pressure" ], "interventions": [ { "name": "CPAP/PEEP", "type": "DEVICE" }, { "name": "Standard management practices", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "NICHD Neonatal Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "10 Minutes", "sex": "ALL", "summary": "Up to 10 Minutes" }, "enrollment_count": 104, "start_date": "2002-07", "completion_date": "2003-01", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 6, "location_summary": "Birmingham, Alabama • San Diego, California • Miami, Florida + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01223274" }, { "nct_id": "NCT04084860", "title": "The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alcohol Use Disorder" ], "interventions": [ { "name": "CI-581a", "type": "DRUG" }, { "name": "CI-581b", "type": "DRUG" }, { "name": "MBRP", "type": "BEHAVIORAL" }, { "name": "MET", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 120, "start_date": "2019-11-08", "completion_date": "2024-08-31", "has_results": false, "last_update_posted_date": "2023-11-07", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04084860" }, { "nct_id": "NCT02893826", "title": "Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Subarachnoid Hemorrhage, Aneurysmal" ], "interventions": [ { "name": "EG-1962 (nimodipine microparticles)", "type": "DRUG" }, { "name": "Enteral Nimodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Edge Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 6, "start_date": "2016-09", "completion_date": "2018-03", "has_results": false, "last_update_posted_date": "2018-07-26", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 3, "location_summary": "Phoenix, Arizona • San Francisco, California • Baltimore, Maryland", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02893826" }, { "nct_id": "NCT06802068", "title": "Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health" ], "interventions": [ { "name": "whole salmon oil", "type": "DIETARY_SUPPLEMENT" }, { "name": "Cod liver oil", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Hofseth Biocare ASA", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 96, "start_date": "2025-02-18", "completion_date": "2026-01-05", "has_results": false, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 2, "location_summary": "Menlo Park, California • San Francisco, California", "locations": [ { "city": "Menlo Park", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06802068" }, { "nct_id": "NCT05076110", "title": "Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hip Arthroscopy" ], "interventions": [ { "name": "Oxycodone", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Methocarbamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 86, "start_date": "2022-04-07", "completion_date": "2025-10-25", "has_results": true, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-11-08T07:26:02.298Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05076110" } ] }